Jump to content
RemedySpot.com

Links to 3 New Hepatitis C articles

Rate this topic


Guest guest

Recommended Posts

Guest guest

J & J Wins European Panel's Backing of Cancer, Hepatitis Drugs

Bloomberg

By Connolly and Nussbaum - Fri Jul 22 16:09:45 GMT 2011 &

(JNJ) won the backing of a European panel today for approval of its

hepatitis C treatment Incivo and prostate-cancer drug Zytiga, each projected by

analysts to top ...

See all stories on this topic »Rapist infected woman with hepatitis C

BBC News

A sex attacker who infected a woman with hepatitis C when he broke into her

south London home and raped her has been jailed indefinitely. The victim, aged

in her 50s, was in bed when she awoke to find Lee Brophy, armed with a knife,

standing over her. ...

See all stories on this topic »Vertex, J & J Hepatitis Drug Moves Closer to EU

Approval

Minyanville.com

Vertex Pharmaceuticals' (VRTX) and & 's (JNJ) hepatitis C drug

moved a step closer to receiving European approval, setting up another battle

with Merck (MRK). A panel of advisers to the European Medicines Agency says the

drug should be ...

See all stories on this topic »

Link to comment
Share on other sites

Guest guest

J & J Wins European Panel's Backing of Cancer, Hepatitis Drugs

Bloomberg

By Connolly and Nussbaum - Fri Jul 22 16:09:45 GMT 2011 &

(JNJ) won the backing of a European panel today for approval of its

hepatitis C treatment Incivo and prostate-cancer drug Zytiga, each projected by

analysts to top ...

See all stories on this topic »Rapist infected woman with hepatitis C

BBC News

A sex attacker who infected a woman with hepatitis C when he broke into her

south London home and raped her has been jailed indefinitely. The victim, aged

in her 50s, was in bed when she awoke to find Lee Brophy, armed with a knife,

standing over her. ...

See all stories on this topic »Vertex, J & J Hepatitis Drug Moves Closer to EU

Approval

Minyanville.com

Vertex Pharmaceuticals' (VRTX) and & 's (JNJ) hepatitis C drug

moved a step closer to receiving European approval, setting up another battle

with Merck (MRK). A panel of advisers to the European Medicines Agency says the

drug should be ...

See all stories on this topic »

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...